BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 18495691)

  • 1. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
    Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
    J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Galphaq interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells.
    Chu CH; Tzang BS; Chen LM; Kuo CH; Cheng YC; Chen LY; Tsai FJ; Tsai CH; Kuo WW; Huang CY
    J Endocrinol; 2008 May; 197(2):381-90. PubMed ID: 18434368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor II receptor, transforming growth factor-beta, and Cdk4 expression and the developmental epigenetics of mouse palate morphogenesis and dysmorphogenesis.
    Melnick M; Chen H; Buckley S; Warburton D; Jaskoll T
    Dev Dyn; 1998 Jan; 211(1):11-25. PubMed ID: 9438420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
    Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
    J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
    Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
    Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
    Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
    J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases.
    Sun CY; Hu Y; Wang HF; He WJ; Wang YD; Wu T
    Chin Med J (Engl); 2006 Apr; 119(7):589-95. PubMed ID: 16620701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leu27IGF2 plays an opposite role to IGF1 to induce H9c2 cardiomyoblast cell apoptosis via Galphaq signaling.
    Chen RJ; Wu HC; Chang MH; Lai CH; Tien YC; Hwang JM; Kuo WH; Tsai FJ; Tsai CH; Chen LM; Huang CY; Chu CH
    J Mol Endocrinol; 2009 Dec; 43(6):221-30. PubMed ID: 19556392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation.
    Lee SD; Chu CH; Huang EJ; Lu MC; Liu JY; Liu CJ; Hsu HH; Lin JA; Kuo WW; Huang CY
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E306-14. PubMed ID: 16825605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
    Ghahary A; Tredget EE; Mi L; Yang L
    Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
    Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
    Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix.
    Miyamoto S; Nakamura M; Yano K; Ishii G; Hasebe T; Endoh Y; Sangai T; Maeda H; Shi-Chuang Z; Chiba T; Ochiai A
    Cancer Sci; 2007 May; 98(5):685-91. PubMed ID: 17359288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type-2 IGF receptor: a multi-ligand binding protein.
    Braulke T
    Horm Metab Res; 1999; 31(2-3):242-6. PubMed ID: 10226808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
    Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
    Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice lacking tissue plasminogen activator and urokinase plasminogen activator genes show attenuated matrix metalloproteases activity after sciatic nerve crush.
    Siconolfi LB; Seeds NW
    J Neurosci Res; 2003 Nov; 74(3):430-4. PubMed ID: 14598319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
    González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.